Stryker Corporation (SYK)

USD 359.17

(-3.14%)

Revenue Summary of Stryker Corporation

  • Stryker Corporation's latest annual revenue in 2023 was 20.49 Billion USD , up 11.11% from previous year.
  • Stryker Corporation's latest quarterly revenue in 2024 Q3 was 5.49 Billion USD , up 1.33% from previous quarter.
  • Stryker Corporation reported a annual revenue of 18.44 Billion USD in annual revenue 2022, up 7.84% from previous year.
  • Stryker Corporation reported a annual revenue of 17.1 Billion USD in annual revenue 2021, up 19.21% from previous year.
  • Stryker Corporation reported a quarterly revenue of 5.42 Billion USD for 2024 Q2, up 3.41% from previous quarter.
  • Stryker Corporation reported a quarterly revenue of 5.49 Billion USD for 2024 Q3, up 1.33% from previous quarter.

Annual Revenue Chart of Stryker Corporation (2023 - 1989)

Historical Annual Revenue of Stryker Corporation (2023 - 1989)

Year Revenue Revenue Growth
2023 20.49 Billion USD 11.11%
2022 18.44 Billion USD 7.84%
2021 17.1 Billion USD 19.21%
2020 14.35 Billion USD -3.58%
2019 14.88 Billion USD 9.43%
2018 13.6 Billion USD 9.3%
2017 12.44 Billion USD 9.88%
2016 11.32 Billion USD 13.86%
2015 9.94 Billion USD 2.8%
2014 9.67 Billion USD 7.25%
2013 9.02 Billion USD 4.2%
2012 8.65 Billion USD 4.21%
2011 8.3 Billion USD 13.48%
2010 7.32 Billion USD 8.88%
2009 6.72 Billion USD 0.07%
2008 6.71 Billion USD 11.96%
2007 6 Billion USD 11.01%
2006 5.4 Billion USD 10.96%
2005 4.87 Billion USD 14.29%
2004 4.26 Billion USD 17.57%
2003 3.62 Billion USD 20.38%
2002 3.01 Billion USD 15.73%
2001 2.6 Billion USD 13.67%
2000 2.28 Billion USD 8.83%
1999 2.1 Billion USD 90.69%
1998 1.1 Billion USD 12.56%
1997 980.1 Million USD 7.69%
1996 910.1 Million USD 4.37%
1995 872 Million USD 27.88%
1994 681.9 Million USD 22.36%
1993 557.3 Million USD 16.81%
1992 477.1 Million USD 30.78%
1991 364.8 Million USD 30.01%
1990 280.6 Million USD 24.21%
1989 225.9 Million USD 26.48%

Peer Revenue Comparison of Stryker Corporation

Name Revenue Revenue Difference
Abbott Laboratories 40.1 Billion USD 48.894%
Allurion Technologies Inc. 53.46 Million USD -38237.666%
Artivion, Inc. 354 Million USD -5690.33%
Avanos Medical, Inc. 673.3 Million USD -2944.408%
Butterfly Network, Inc. 65.9 Million USD -31004.704%
Butterfly Network, Inc. 65.9 Million USD -31004.704%
Bio-Rad Laboratories, Inc. 2.67 Billion USD -667.353%
Boston Scientific Corporation 14.24 Billion USD -43.947%
Perspective Therapeutics, Inc. 7.1 Million USD -288441.667%
CONMED Corporation 1.24 Billion USD -1551.794%
Edwards Lifesciences Corporation 6 Billion USD -241.36%
Paragon 28, Inc. 216.38 Million USD -9372.755%
Glaukos Corporation 314.71 Million USD -6413.277%
Globus Medical, Inc. 1.56 Billion USD -1206.874%
Inspire Medical Systems, Inc. 624.79 Million USD -3180.735%
Integer Holdings Corporation 1.59 Billion USD -1183.794%
Medtronic plc 32.36 Billion USD 36.664%
Nevro Corp. 425.17 Million USD -4721.085%
Owlet, Inc. 54.01 Million USD -37852.231%
Penumbra, Inc. 1.05 Billion USD -1836.474%
Vicarious Surgical Inc. - USD -Infinity%
Smith & Nephew plc 5.54 Billion USD -269.4%
Sonendo, Inc. 43.86 Million USD -46629.739%
STERIS plc 5.13 Billion USD -298.895%
Vapotherm, Inc. 68.66 Million USD -29750.442%
Zimmer Biomet Holdings, Inc. 7.39 Billion USD -177.217%